ST. LOUIS, Dec. 18, 2023 /PRNewswire/ — Ameren Corporation (NYSE: AEE) announced today the pricing of a public offering of $700 million aggregate principal amount of its 5.00% senior notes due 2029 at 99.774% of their principal amount. The transaction is expected to close on December 21, 2023, subject to the satisfaction of customary closing… Continue reading Ameren Announces Pricing of Senior Notes due 2029
Category: Newswire
Global Healthcare Revenue Cycle Management Market Report 2023-2028: Burgeoning Opportunities in Conversational AI for Front-end RCM, Automation for Efficiency, Hybrid Approach, and Blockchain
DUBLIN , Dec. 18, 2023 /PRNewswire/ — The “Global Healthcare Revenue Cycle Management Market, Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. This report is a comprehensive guide for senior executives seeking to capitalize on the advancements in RCM solutions. It delves into how the synergy of intelligent technologies-such as conversational AI and automation-is primed to revolutionize… Continue reading Global Healthcare Revenue Cycle Management Market Report 2023-2028: Burgeoning Opportunities in Conversational AI for Front-end RCM, Automation for Efficiency, Hybrid Approach, and Blockchain
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
ROCKVILLE, Md. and SUZHOU, China, Dec. 18, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, and AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, today… Continue reading Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
PARRIS Law Firm Collects 190 Toys to Support the Salvation Army’s Annual Angel Tree Program
LANCASTER, Calif., Dec. 18, 2023 /PRNewswire/ — PARRIS Law Firm, founded by renowned trial attorney R. Rex Parris, collected 190 toys to support the Antelope Valley’s branch of The Salvation Army’s Angel Tree Program. Thanks to their contributions, 55 children in the Antelope Valley will wake up on Christmas morning with presents under their tree.… Continue reading PARRIS Law Firm Collects 190 Toys to Support the Salvation Army’s Annual Angel Tree Program
BioTelemetry and LifeWatch Agree to Pay Nearly $13 Million to Settle False Claims Act Case Brought by Whistleblower Law Collaborative Client
BOSTON, Dec. 18, 2023 /PRNewswire/ — Whistleblower Law Collaborative LLC is pleased to announce that the United States has settled a False Claims Act case brought by one of its clients. Under the terms of the settlement, BioTelemetry, Inc. and LifeWatch Services, Inc. (“Defendants”) will pay $12,936,574, plus interest, to resolve allegations that they submitted false claims to… Continue reading BioTelemetry and LifeWatch Agree to Pay Nearly $13 Million to Settle False Claims Act Case Brought by Whistleblower Law Collaborative Client
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of R1 RCM Inc. – RCM
NEW YORK, Dec. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of R1 RCM Inc. (“RCM” or the “Company”) (NASDAQ: RCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether RCM and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of R1 RCM Inc. – RCM
LIQUID META ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
TORONTO, Dec. 18, 2023 /PRNewswire/ – Liquid Meta Capital Holdings Ltd. (“Liquid Meta” or the “Company”) (NEO: LIQD) (FRANKFURT: N5F) (OTCQB: LIQQF) announces the results of its annual general meeting of shareholders (the “Meeting”) held on December 18, 2023. At the Meeting, each of Jonathan Wiesblatt, Nicolas del Pino, David Prussky and Michael Ostfield were elected… Continue reading LIQUID META ANNOUNCES RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Braskem S.A. – BAK
NEW YORK, Dec. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Braskem S.A., Inc. (“Braskem” or the “Company”) (NYSE: BAK). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Braskem and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Braskem S.A. – BAK
Lumina Gold Announces Issuance of Annual Equity Incentive Grant
VANCOUVER, BC, Dec. 18, 2023 /PRNewswire/ – Lumina Gold Corp. (TSXV: LUM) (OTCQB: LMGDF) (the “Company” or “Lumina”) announces that it has granted incentive stock options and restricted share units (“RSU’s”) under the Company’s Omnibus Equity Incentive Plan to certain directors, officers, employees and consultants of the Company. 5,635,000 stock options were granted and have an… Continue reading Lumina Gold Announces Issuance of Annual Equity Incentive Grant
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Toyota Motor Corporation – TM
NEW YORK, Dec. 18, 2023 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Toyota Motor Corporation (“Toyota” or the “Company”) (NYSE: TM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Toyota and certain of its officers and/or directors have engaged in securities fraud or other… Continue reading SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Toyota Motor Corporation – TM